Genetic Testing for Potentially Lethal, Highly Treatable Inherited Cardiomyopathies/Channelopathies in Clinical Practice
- 8 March 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 123 (9), 1021-1037
- https://doi.org/10.1161/circulationaha.109.914838
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Gain-of-function mutation S422L in the KCNJ8-encoded cardiac KATP channel Kir6.1 as a pathogenic substrate for J-wave syndromesHeart Rhythm, 2010
- The RYR2-Encoded Ryanodine Receptor/Calcium Release Channel in Patients Diagnosed Previously With Either Catecholaminergic Polymorphic Ventricular Tachycardia or Genotype Negative, Exercise-Induced Long QT SyndromeJournal of the American College of Cardiology, 2009
- Genotype-Phenotype Aspects of Type 2 Long QT SyndromeJournal of the American College of Cardiology, 2009
- An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testingHeart Rhythm, 2009
- Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION® long QT syndrome genetic testHeart Rhythm, 2009
- Ranolazine Shortens Repolarization in Patients with Sustained Inward Sodium Current Due to Type‐3 Long‐QT SyndromeJournal of Cardiovascular Electrophysiology, 2008
- Next-Generation DNA Sequencing MethodsAnnual Review of Genomics and Human Genetics, 2008
- Novel gene and mutation discovery in congenital long QT syndrome: Let's keep looking where the street lamp standethHeart Rhythm, 2008
- Multiplex amplification of large sets of human exonsNature Methods, 2007
- Clinical genetics in cardiologyHeart, 2006